Promising new treatment for dementia patients
A promising new treatment for a very troubling symptom of dementia.
Phase-3 clinical trials show the antipsychotic drug, Pimavanserin, significantly reduced hallucinations and delusions in dementia patients.
Scientists from the Cleveland Clinic even stopped the study early because the benefit was so clear.
The drugmaker, Acadia Pharmaceutical, now plans to apply for FDA approval.
About 30%, or over 2-million dementia patients suffer from delusions that can cause aggressive behavior.
Copyright 2019 NBC News. All rights reserved.